Market Overview Global 3D Ultrasound Market size and share is currently valued at USD 3.72 billion in 2024 and is anticipated to generate an estimated revenue of USD 7.81 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 7.7% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 -...

According to a recent report published by Grand View Research, Inc., the global cell and gene therapy bioanalytical testing services market is projected to reach a valuation of USD 828.7 million by the year 2030. The market is expected to grow at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2030. This growth is being driven primarily by several key factors, including...

Enteric Disease Testing Industry The global enteric disease testing market size was valued at USD 3.81 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 2.7% from 2023 to 2030. Vital drivers of this market include technological advancements and supportive government funding in emerging economies. Furthermore, growing global demand for early diagnostics is...

Enteric Disease Testing Industry The global enteric disease testing market size is expected to reach USD 4.68 billion by 2030, registering a CAGR of 2.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing demand for rapid diagnosis in order to treat diseases such as cholera, and other diarrheal diseases, rise in the aging population accompanied by unhygienic...

The global enteric disease testing market was valued at USD 3.81 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 2.7% from 2023 to 2030. The key drivers for this growth include technological advancements, increased government funding, and growing global demand for early diagnostic solutions. These factors are enhancing the applicability of enteric...

The global enteric disease testing market is poised for significant growth, with a projected value of USD 3.13 billion by 2030, growing at a CAGR of 6.1% over the forecast period. The growth is fueled by the increasing prevalence of gastrointestinal infections worldwide, growing awareness of foodborne diseases, and technological advancements in diagnostic solutions. Enteric diseases,...

The global enteric disease testing market was valued at approximately USD 3.81 billion in 2022 and is projected to experience growth at a compound annual growth rate (CAGR) of 2.7% from 2023 to 2030. Key drivers behind this market expansion include ongoing technological advancements and supportive government funding, particularly in emerging economies. Furthermore, there is an...